title: New insights into the catalytic mechanism of histidine phosphatases revealed by a functionally essential arginine residue within the active site of the Sts phosphatases.
abstract: Sts (suppressor of T-cell receptor signalling)-1 and Sts-2 are HPs (histidine phosphatases) that negatively regulate TCR (T-cell receptor) signalling pathways, including those involved in cytokine production. HPs play key roles in such varied biological processes as metabolism, development and intracellular signalling. They differ considerably in their primary sequence and substrate specificity, but possess a catalytic core formed by an invariant quartet of active-site residues. Two histidine and two arginine residues cluster together within the HP active site and are thought to participate in a two-step dephosphorylation reaction. To date there has been little insight into any additional residues that might play an important functional role. In the present study, we identify and characterize an additional residue within the Sts phosphatases (Sts-1 Arg383 or Sts-2 Arg369) that is critical for catalytic activity and intracellular function. Mutation of Sts-1 Arg383 to an alanine residue compromises the enzyme's activity and renders Sts-1 unable to suppress TCR-induced cytokine induction. Of the multiple amino acids substituted for Arg383, only lysine partially rescues the catalytic activity of Sts-1. Although Sts-1 Arg383 is conserved in all Sts homologues, it is only conserved in one of the two sub-branches of HPs. The results of the present study highlight an essential role for Sts-1 phosphatase activity in regulating T-cell activation and add a new dimension of complexity to our understanding of HP catalytic activity.
authors.affiliation: Department of Molecular Genetics and Microbiology, Room 130, Life Sciences Building, Stony Brook University, Stony Brook, NY 11794-5222, USA.
authors.forename: Boris
authors.initials: B
authors.lastname: San Luis
authors.forename: Nicolas
authors.initials: N
authors.lastname: Nassar
authors.forename: Nick
authors.initials: N
authors.lastname: Carpino
mesh_terms: D001120:Arginine / Q000737:chemistry* / Q000378:metabolism; D020134:Catalytic Domain; D057809:HEK293 Cells; D006801:Humans; D010744:Phosphoric Monoester Hydrolases / Q000378:metabolism*; D017027:Protein Tyrosine Phosphatases / Q000378:metabolism*
chemical_list: D001120:Arginine; D010744:Phosphoric Monoester Hydrolases; D017027:Protein Tyrosine Phosphatases; C489397:UBASH3B protein, human
references.citation: Immunol Rev. 2003 Apr;192:143-60
references.pmid: 12670402
references.citation: Prog Biophys Mol Biol. 2000;73(2-4):263-87
references.pmid: 10958932
references.citation: Blood. 2010 Oct 7;116(14):2570-8
references.pmid: 20585042
references.citation: Structure. 1996 Sep 15;4(9):1017-29
references.pmid: 8805587
references.citation: EMBO J. 1993 Jul;12(7):2609-15
references.pmid: 8334986
references.citation: Curr Opin Immunol. 2003 Jun;15(3):315-20
references.pmid: 12787757
references.citation: PLoS Genet. 2011 Feb;7(2):e1002004
references.pmid: 21383967
references.citation: Immunol Rev. 2011 May;241(1):133-44
references.pmid: 21488895
references.citation: J Mol Biol. 2002 Mar 8;316(5):1071-81
references.pmid: 11884145
references.citation: J Biol Chem. 2001 Feb 2;276(5):3247-53
references.pmid: 11038361
references.citation: Nat Rev Immunol. 2002 Jun;2(6):427-38
references.pmid: 12093009
references.citation: Curr Opin Immunol. 2002 Dec;14(6):744-59
references.pmid: 12413525
references.citation: Autoimmun Rev. 2012 Jul;11(9):664-9
references.pmid: 22155015
references.citation: Mol Cell. 2007 Aug 3;27(3):486-97
references.pmid: 17679096
references.citation: J Cell Physiol. 2013 Jan;228(1):43-9
references.pmid: 22689384
references.citation: Nat Struct Biol. 1997 Mar;4(3):185-90
references.pmid: 9164457
references.citation: Biochem J. 2003 Apr 1;371(Pt 1):15-27
references.pmid: 12485116
references.citation: Structure. 2004 Sep;12(9):1575-83
references.pmid: 15341723
references.citation: Annu Rev Immunol. 2009;27:591-619
references.pmid: 19132916
references.citation: J Biol Chem. 2011 May 6;286(18):15943-54
references.pmid: 21393235
references.citation: Cell Mol Life Sci. 2009 Sep;66(17):2949-52
references.pmid: 19585081
references.citation: Nat Immunol. 2010 Jan;11(1):21-7
references.pmid: 20016506
references.citation: Arthritis Res Ther. 2009;11(3):R66
references.pmid: 19442274
references.citation: N Engl J Med. 1987 May 21;316(21):1320-5
references.pmid: 3553948
references.citation: Mol Cell Biol. 2005 Jun;25(12):4924-33
references.pmid: 15923611
references.citation: J Biol Chem. 2010 Oct 8;285(41):31268-76
references.pmid: 20670933
references.citation: Expert Rev Mol Med. 2005 Dec 19;7(29):1-29
references.pmid: 16364187
references.citation: Biochemistry. 2009 Sep 1;48(34):8129-35
references.pmid: 19627098
references.citation: Biochem J. 2008 Jan 15;409(2):333-48
references.pmid: 18092946
references.citation: J Allergy Clin Immunol. 2003 Feb;111(2 Suppl):S476-85
references.pmid: 12592294
references.citation: Immunity. 2004 Jan;20(1):37-46
references.pmid: 14738763
references.citation: N Engl J Med. 2010 May 6;362(18):1686-97
references.pmid: 20410501
references.citation: Nat Immunol. 2012 Jan 19;13(2):121-8
references.pmid: 22261968
references.citation: Diabetes. 2008 Oct;57(10):2858-61
references.pmid: 18647951
references.citation: Nat Rev Immunol. 2005 Jun;5(6):472-84
references.pmid: 15928679
references.citation: Biochemistry. 2009 Mar 3;48(8):1681-90
references.pmid: 19196006